Patrick G. Gavin

3.1k total citations · 1 hit paper
32 papers, 2.1k citations indexed

About

Patrick G. Gavin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Patrick G. Gavin has authored 32 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Patrick G. Gavin's work include Colorectal Cancer Treatments and Studies (12 papers), Genetic factors in colorectal cancer (8 papers) and Gastric Cancer Management and Outcomes (6 papers). Patrick G. Gavin is often cited by papers focused on Colorectal Cancer Treatments and Studies (12 papers), Genetic factors in colorectal cancer (8 papers) and Gastric Cancer Management and Outcomes (6 papers). Patrick G. Gavin collaborates with scholars based in United States, South Korea and Australia. Patrick G. Gavin's co-authors include Soonmyung Paik, Robert H. Dworkin, Charles L. Loprinzi, Maryam B. Lustberg, Judith A. Paice, Thomas J. Smith, Cynthia Chauhan, Nina D. Wagner‐Johnston, Kate Bak and Dawn L. Hershman and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Diabetes Care.

In The Last Decade

Patrick G. Gavin

32 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

2014 887 citations Patrick G. Gavin et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick G. Gavin United States	16	1.4k	450	385	331	321	32	2.1k
Gamini S. Soori United States	23	1.6k 1.2×	428 1.0×	263 0.7×	642 1.9×	373 1.2×	70	2.6k
Eun‐Soon Shin South Korea	31	701 0.5×	811 1.8×	221 0.6×	332 1.0×	262 0.8×	101	2.7k
Ryo Takahashi Japan	25	413 0.3×	434 1.0×	191 0.5×	315 1.0×	295 0.9×	106	2.1k
Wei-Shu Wang Taiwan	23	662 0.5×	405 0.9×	156 0.4×	243 0.7×	108 0.3×	54	1.7k
Yuan Tang China	23	636 0.5×	429 1.0×	345 0.9×	415 1.3×	79 0.2×	209	1.8k
Céline C. Berthier United States	31	262 0.2×	1.0k 2.3×	221 0.6×	303 0.9×	200 0.6×	66	3.6k
D. Creamer United Kingdom	23	218 0.2×	344 0.8×	474 1.2×	145 0.4×	531 1.7×	74	2.4k
F. Ries Luxembourg	21	622 0.4×	330 0.7×	323 0.8×	325 1.0×	40 0.1×	70	1.7k
Giusy Elia Italy	26	508 0.4×	528 1.2×	388 1.0×	238 0.7×	38 0.1×	77	2.5k
Stuart Osborne Switzerland	19	919 0.7×	139 0.3×	305 0.8×	359 1.1×	79 0.2×	56	1.7k

Countries citing papers authored by Patrick G. Gavin

Since Specialization

Citations

This map shows the geographic impact of Patrick G. Gavin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick G. Gavin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick G. Gavin more than expected).

Fields of papers citing papers by Patrick G. Gavin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick G. Gavin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick G. Gavin. The network helps show where Patrick G. Gavin may publish in the future.

Co-authorship network of co-authors of Patrick G. Gavin

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick G. Gavin. A scholar is included among the top collaborators of Patrick G. Gavin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick G. Gavin. Patrick G. Gavin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baker, Tina, Paul J. Newcombe, Patrick G. Gavin, et al.. (2024). Type I interferon blockade with anifrolumab in patients with systemic lupus erythematosus modulates key immunopathological pathways in a gene expression and proteomic analysis of two phase 3 trials. Annals of the Rheumatic Diseases. 83(8). 1018–1027. 32 indexed citations

Gavin, Patrick G., K. W. Kim, Maria E. Craig, Michelle M. Hill, & Emma E. Hamilton‐Williams. (2022). Multi-omic interactions in the gut of children at the onset of islet autoimmunity. Microbiome. 10(1). 230–230. 10 indexed citations

Yap, Yu Anne, Keiran H McLeod, Craig I. McKenzie, et al.. (2021). An acetate‐yielding diet imprints an immune and anti‐microbial programme against enteric infection. Clinical & Translational Immunology. 10(1). e1233–e1233. 33 indexed citations

Gavin, Patrick G., et al.. (2021). Metaproteomic sample preparation methods bias the recovery of host and microbial proteins according to taxa and cellular compartment. Journal of Proteomics. 240. 104219–104219. 6 indexed citations

Gavin, Patrick G. & Emma E. Hamilton‐Williams. (2019). The gut microbiota in type 1 diabetes: friend or foe?. Current Opinion in Endocrinology Diabetes and Obesity. 26(4). 207–212. 33 indexed citations

Chumsri, Saranya, Zhuo Li, Daniel Serie, et al.. (2019). Incidence of Late Relapses in Patients With HER2-Positive Breast Cancer Receiving Adjuvant Trastuzumab: Combined Analysis of NCCTG N9831 (Alliance) and NRG Oncology/NSABP B-31. Journal of Clinical Oncology. 37(35). 3425–3435. 50 indexed citations

Pogue–Geile, Katherine L., Thierry André, Nan Song, et al.. (2019). Association of colon cancer (CC) molecular signatures with prognosis and oxaliplatin prediction-benefit in the MOSAIC Trial (Multicenter International Study of Oxaliplatin/5FU-LV in the Adjuvant Treatment of Colon Cancer).. Journal of Clinical Oncology. 37(15_suppl). 3503–3503. 6 indexed citations

Pal, Rekha, Ning Wei, Nan Song, et al.. (2018). Molecular subtypes of colorectal cancer in pre-clinical models show differential response to targeted therapies: Treatment implications beyond KRAS mutations. PLoS ONE. 13(8). e0200836–e0200836. 8 indexed citations

Mullaney, Jane, Patrick G. Gavin, Casey M. Wright, et al.. (2018). Type 1 diabetes susceptibility alleles are associated with distinct alterations in the gut microbiota. Microbiome. 6(1). 35–35. 92 indexed citations

10.

Gavin, Patrick G., Jane Mullaney, Dorothy Loo, et al.. (2018). Intestinal Metaproteomics Reveals Host-Microbiota Interactions in Subjects at Risk for Type 1 Diabetes. Diabetes Care. 41(10). 2178–2186. 104 indexed citations

11.

Kim, Rim S., Nan Song, Patrick G. Gavin, et al.. (2018). NRG Oncology/NSABP B-31: Stromal tumor infiltrating lymphocytes (sTILs) and outcomes in early-stage HER2-positive breast cancer (BC).. Journal of Clinical Oncology. 36(15_suppl). 12010–12010. 3 indexed citations

12.

Song, Nan, Greg Yothers, Patrick G. Gavin, et al.. (2017). Tumour sidedness and intrinsic subtypes in patients with stage II/III colon cancer: analysis of NSABP C-07 (NRG Oncology). British Journal of Cancer. 118(5). 629–633. 20 indexed citations

13.

Srinivasan, Ashok, Carmen J. Allegra, Samuel A. Jacobs, et al.. (2017). Abstract 5684: NSABP FC-7 correlative study: HER2 amplification (amp) in circulating cell-free DNA (cfDNA) in metastatic colorectal cancer (mCRC) resistant to anti-EGFR therapy (tx). Cancer Research. 77(13_Supplement). 5684–5684. 2 indexed citations

14.

Kim, Seong-Rim, Patrick G. Gavin, Katherine L. Pogue–Geile, et al.. (2015). Abstract 2837: A surrogate gene expression signature of tumor infiltrating lymphocytes (TILs) predicts degree of benefit from trastuzumab added to standard adjuvant chemotherapy in NSABP (NRG) trial B-31 for HER2+ breast cancer. Cancer Research. 75(15_Supplement). 2837–2837. 13 indexed citations

15.

Pogue–Geile, Katherine L., Nan Song, Jong‐Hyeon Jeong, et al.. (2015). Intrinsic Subtypes, PIK3CA Mutation, and the Degree of Benefit From Adjuvant Trastuzumab in the NSABP B-31 Trial. Journal of Clinical Oncology. 33(12). 1340–1347. 80 indexed citations

16.

Chera, Bhishamjit S., Avraham Eisbruch, Barbara A. Murphy, et al.. (2014). Recommended Patient-Reported Core Set of Symptoms to Measure in Head and Neck Cancer Treatment Trials. JNCI Journal of the National Cancer Institute. 106(7). 52 indexed citations

17.

Pogue-Geile, Kay L., Greg Yothers, Yusuke Taniyama, et al.. (2013). Defective Mismatch Repair and Benefit from Bevacizumab for Colon Cancer: Findings from NSABP C-08. JNCI Journal of the National Cancer Institute. 105(13). 989–992. 52 indexed citations

18.

Gavin, Patrick G., Linda H. Colangelo, Debora Fumagalli, et al.. (2012). Mutation Profiling and Microsatellite Instability in Stage II and III Colon Cancer: An Assessment of Their Prognostic and Oxaliplatin Predictive Value. Clinical Cancer Research. 18(23). 6531–6541. 240 indexed citations

19.

Fumagalli, Debora, Patrick G. Gavin, Yusuke Taniyama, et al.. (2010). A rapid, sensitive, reproducible and cost-effective method for mutation profiling of colon cancer and metastatic lymph nodes. BMC Cancer. 10(1). 101–101. 108 indexed citations

20.

Tobias, Karen M., et al.. (2001). Cyanoacrylate occlusion and resection of an arteriovenous fistula in a cat. Journal of the American Veterinary Medical Association. 219(6). 785–788. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact